[6,7-Bis(2-methoxy-ethoxy)-quinazolin4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
Details for Australian Patent Application No. 2004212067 (hide)
International Classifications
Event Publications
8 September 2005 PCT application entered the National Phase
PCT publication WO2004/072049 Priority application(s): WO2004/072049
19 March 2009 Application Accepted
Published as AU-B-2004212067
28 May 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 04 May 2009. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000
24 September 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 May 2009
24 September 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004212083-Signal amplification method for detecting expressed gene
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser